2
Clinical Trials associated with MCV-ACYW135 Vaccine(Beijing Minhai Biotechnology Co., Ltd)对2月龄至6周岁儿童进行的ACYW135群脑膜炎球菌结合疫苗随机、双盲、平行对照试验
[Translation] A randomized, double-blind, parallel controlled trial of ACYW135 group meningococcal conjugate vaccine in children aged 2 months to 6 years
评价ACYW135群脑膜炎球菌结合疫苗应用于2月龄至6周岁儿童的安全性和免疫原性。
[Translation] To evaluate the safety and immunogenicity of group ACYW135 meningococcal conjugate vaccine in children aged 2 months to 6 years.
Immunogenicity and Safety of Meningococcal (A, C, Y and W135) Conjugate Vaccine in Healthy Subjects 2 Months to 6 Years of Age in China
The purpose of this observer-blind study is to evaluate the safety, reactogenicity and immunogenicity of Meninggococcal (A,C,Y and W135) Conjugate Vaccine in 2 months to 6 years-old children.
100 Clinical Results associated with MCV-ACYW135 Vaccine(Beijing Minhai Biotechnology Co., Ltd)
100 Translational Medicine associated with MCV-ACYW135 Vaccine(Beijing Minhai Biotechnology Co., Ltd)
100 Patents (Medical) associated with MCV-ACYW135 Vaccine(Beijing Minhai Biotechnology Co., Ltd)
100 Deals associated with MCV-ACYW135 Vaccine(Beijing Minhai Biotechnology Co., Ltd)